Bard Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-230
| Closed | -$242K | – | 211 |
|
|
2024
Q3 | $242K | Sell |
230
-25
| -10% | -$26.3K | 0.03% | 184 |
|
|
2024
Q2 | $268K | Sell |
255
-25
| -9% | -$26.3K | 0.03% | 189 |
|
|
2024
Q1 | $269K | Hold |
280
| – | – | 0.03% | 195 |
|
|
2023
Q4 | $246K | Hold |
280
| – | – | 0.03% | 203 |
|
|
2023
Q3 | $230K | Sell |
280
-45
| -14% | -$37K | 0.03% | 201 |
|
|
2023
Q2 | $234K | Hold |
325
| – | – | 0.02% | 277 |
|
|
2023
Q1 | $267K | Sell |
325
-25
| -7% | -$20.5K | 0.02% | 272 |
|
|
2022
Q4 | $253K | Sell |
350
-50
| -13% | -$36.1K | 0.02% | 261 |
|
|
2022
Q3 | $276K | Hold |
400
| – | – | 0.03% | 243 |
|
|
2022
Q2 | $236K | Hold |
400
| – | – | 0.02% | 255 |
|
|
2022
Q1 | $279K | Hold |
400
| – | – | 0.02% | 248 |
|
|
2021
Q4 | $253K | Hold |
400
| – | – | 0.02% | 251 |
|
|
2021
Q3 | $242K | Hold |
400
| – | – | 0.02% | 244 |
|
|
2021
Q2 | $223K | Buy |
+400
| New | +$223K | 0.02% | 249 |
|